Newly approved additives will be used to made surgically implanted devices safer, more successful
What began in the Dentistry lab of Professor Paul Santerre more than a decade ago is now Interface Biologics Inc. (IBI) - a privately-held company poised to transform the market for medical devices in the United States.
Sep 19, 2012
0
0